RMacchio
3 weeks ago
finally provide a more level chance for others to achieve success and at a quicker pace
The recent approvals of mRNA vaccines, Remdesivir, Paxlovid, and Lecanemab, despite little to no efficacy, are a stain on the NIH. Hopefully the day of Big Pharma dominance has come to an end and the NIH begins to focus on rigorous scientific evidence. Given the lightning speed of change under the new administration this transition could happen very quickly.
Ecomike
3 weeks ago
The other galectin inhibitor drug stock, GALT released awesome news today on their Liver MASH trials, that will spill over into folks finally getting what $BIXT has, because $BIXT has a perfect trial already for N1H1 Covid, proof of their AI perfected antiviral, and is expanding into the Cancer treatment field to help triple the Merck Keytruda cancer cure from about 30% to about 100% effective, by pursuing a JV to show that their Galectin-3 Inhibitor can solve the Keytruda cancer-cure Galectin 3 problem, that is holding back the cure rate to Keytruda. Also they should be closing the door on Bird flu, etc, virus antiviral applications pretty soon.
Ecomike
1 month ago
Depending on the events and timeline, and Licensing and JV terms, anywhere from $10 to $100/share, if licensing fees go to share buybacks, and reduce the OS share count, and if not bought out first by a SPAC , and if dividends start being paid....it can be a monster
Ecomike
2 months ago
The officers passed up on taking their pay checks to conserve cash, and took shares at way higher prices in prior years.
Very bullish buy signal.
They converted the common shares to Preferred shares, also super bullish.
The OS tradable shares dropped 50%.
All old news. None of which matters now.
Moderna just scored 570 Million dollars to develop another clot shot that will not work, and no will take, for Bird flue on Humans.
It was political. But Moderna is just another clot shot, fake Vaccine, no one will trust. Moderna product has side effects.
BIXT Galectin-3 is the worlds first, proven, non-toxic, oral pill, proven in successful phase II trials, BROAD Spectrum Antiviral in the world. Patented, and will work on Bird Flu, just like it does on other viruses.
Ever heard of BARDA? Hint....
No way $BIXT does not get noticed and fully funded now.